Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.22.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 13,148 $ 3,333
Short term cash deposits 30,151  
Restricted deposit 13 12
Trade receivables 270 830
Other accounts receivable and prepaid expenses 424 239
Inventories 1,081 1,262
Total current assets 45,087 5,676
Non-current assets:    
Restricted deposit 213 181
Operating lease right-of-use assets 2,953 2,796
Property and equipment, net 2,728 2,106
Intangible assets 243 82
Total non-current assets 6,137 5,165
Total assets 51,224 10,841
Current liabilities:    
Trade payables 1,034 798
Operating lease liabilities 519 440
Deferred revenues 32 207
Accrued liabilities and other 1,429 1,943
Total current liabilities 3,014 3,388
Non-current liabilities:    
Derivatives liability   28
Operating lease liabilities 3,089 2,948
Total non-current liabilities 3,089 2,976
Total liabilities 6,103 6,364
Commitments and contingencies
Shareholders’ Equity:    
Ordinary shares, NIS 1.5 par value - authorized: 30,000,000 ordinary shares as of December 31, 2021 and December 31, 2020; issued and outstanding: 10,772,024 and 6,963,838 ordinary shares as of December 31, 2021 and December 31, 2020, respectively 4,664 2,933
Additional paid in capital 114,223 75,547
Currency translation differences (969) (969)
Accumulated deficit (72,797) (73,034)
Total shareholders’ equity 45,121 4,477
Total liabilities and shareholders’ equity $ 51,224 $ 10,841